ANGIODYNAMICS INC 8-K

What Happened
AngioDynamics, Inc. announced its financial results for the fiscal third quarter ended February 28, 2026 and filed an 8‑K on April 2, 2026 to furnish the related press release and investor presentation. The company provided the press release as Exhibit 99.1 and the presentation slides as Exhibit 99.2 in the filing.

Key Details

• Filing date: April 2, 2026 (Form 8‑K).
• Reporting period: fiscal third quarter ended February 28, 2026.
• Exhibits furnished: Press release (Exhibit 99.1) and Presentation slides (Exhibit 99.2).
• Item references: Item 2.02 (Results of operations and financial condition) and Item 7.01 (Regulation FD disclosure).

Why It Matters
This 8‑K signals AngioDynamics has publicly released its quarterly earnings materials; investors should review the press release and slides for revenue, earnings, cash flow, and any guidance or management commentary that could affect the stock. The Regulation FD disclosure indicates the company simultaneously shared these materials with the public, so the exhibits contain the substantive details needed to evaluate the quarter.